Kevin Kloosterman, M.S., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 W Elm St Ste 103, Sycamore, IL 60178 Phone: 815-895-8382 |
Cindy Halstead Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 240 Edward St, Sycamore, IL 60178 Phone: 847-707-2689 |
Emily K Hummel, M.S., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 721 Croatian Ct, Sycamore, IL 60178 Phone: 815-751-3479 |
Tyler Martawibawa Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 240 Edward St, Sycamore, IL 60178 Phone: 847-707-2689 |
Sarah Williams, M.A. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1625 Bethany Rd, Sycamore, IL 60178 Phone: 779-777-7335 Fax: 815-758-8441 |
Brooke Christenson Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 240 Edward St, Sycamore, IL 60178 Phone: 847-707-2689 |
Amanda Ruppert Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1625 Bethany Rd, Sycamore, IL 60178 Phone: 779-777-7335 Fax: 815-758-7441 |
News Archive
A recent study by researchers from Poland, published in the journal Vaccines, shows how levels of IgA and IgG antibodies specific to the spike glycoprotein of SARS-CoV-2 increase in both breast milk and serum samples of mothers following vaccination against COVID-19 – with important implications for further vaccine planning endeavors.
Studying HIV-1, the most common and infectious HIV subtype, Johns Hopkins scientists have identified 25 human proteins "stolen" by the virus that may be critical to its ability to infect new cells. HIV-1 viruses capture many human proteins from the cells they infect but the researchers believe these 25 proteins may be particularly important because they are found in HIV-1 viruses coming from two very different types of infected cells.
In recent years, women who start taking bisphosphonates to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report.
Pevion Biotech, the Swiss vaccine company, today announced that it has successfully completed the preclinical safety and efficacy studies of its RSV vaccine candidate PEV4. The vaccine candidate is a modern subunit vaccine candidate against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech's proprietary and market-validated virosome technology platform.
An international team of experts led by researchers in the Perelman School of Medicine at the University of Pennsylvania and University of Glasgow has been awarded a $9.7 million, five-year grant from the National Institute of Neurological Disorders and Stroke and National Institute for Aging to establish CONNECT-TBI-a program spanning 12 institutions which will study traumatic brain injury and related neurodegenerative diseases.
› Verified 3 days ago